These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6768093)

  • 21. The effect of 6-hydroxydopamine on the antinociceptive action of oxotremorine.
    Slater P
    Psychopharmacology (Berl); 1981; 74(4):365-8. PubMed ID: 6794084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desmethylimipramine pretreatment prevents 6-hydroxydopamine induced somatostatin receptor reduction in the rat hippocampus.
    López-Sañudo S; Arilla E
    Regul Pept; 1992 Oct; 41(3):227-36. PubMed ID: 1438990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive and stimulant effects of morphine after chemical sympathectomy.
    Navarro G
    Pharmacology; 1976; 14(3):265-73. PubMed ID: 959325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation.
    Herve D; Studler JM; Blanc G; Glowinski J; Tassin JP
    Brain Res; 1986 Sep; 383(1-2):47-53. PubMed ID: 3094831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.
    Commins DL; Shaughnessy RA; Axt KJ; Vosmer G; Seiden LS
    J Neural Transm; 1989; 77(2-3):197-210. PubMed ID: 2503586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of 6-hydroxydopamine induced alteration of the postnatal development of central noradrenaline neurons.
    Jonsson G; Hallman H
    Brain Res Bull; 1982; 9(1-6):635-40. PubMed ID: 6184133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of depletion of brain catecholamines during the development of morphine dependence on precipitated withdrawal in rats.
    Bläsig J; Herz A; Gramsch C
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 286(4):325-36. PubMed ID: 238137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of morphine analgesia in morphine-tolerant rats after the intraventricular administration of 6-hydroxydopamine.
    Nakamura K; Kuntzman R; Maggio A; Conney AH
    J Pharm Pharmacol; 1973 Jul; 25(7):584-7. PubMed ID: 4147063
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny.
    Sachs C; Jonsson G
    Brain Res; 1975 Dec; 99(2):277-91. PubMed ID: 1182547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity responses to morphine and amphetamine in rats with elevated NE levels in the pons.
    Olds ME; Fobes JL
    Pharmacol Biochem Behav; 1981 Aug; 15(2):167-71. PubMed ID: 7312890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME; Yuwiler A
    Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine.
    Stockmeier CA; Larsen BR; Blask DE
    J Neurosci Res; 1985; 14(2):279-84. PubMed ID: 3930758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of the periaqueductal grey matter and spinal 5-hydroxytryptaminergic pathways in morphine analgesia: effcts of lesions and 5-hydroxytryptamine depletion.
    Deakin JF; Dostrovsky JO
    Br J Pharmacol; 1978 May; 63(1):159-65. PubMed ID: 206302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of dopamine in the development of spontaneous hypertension.
    van den Buuse M; Versteeg DH; de Jong W
    Hypertension; 1984; 6(6 Pt 1):899-905. PubMed ID: 6519747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of noradrenergic and dopaminergic nerves in the rat kidney: evidence against significant dopaminergic innervation.
    McGrath BP; Lim AE; Bode K; Willis GL; Smith GC
    Clin Exp Pharmacol Physiol; 1983; 10(5):543-53. PubMed ID: 6416723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of morphine on circling behaviour in rats with 6-hydroxydopamine striatal lesions and electrolesions of the raphe nucleus.
    Slater P
    Pharmacol Biochem Behav; 1981 May; 14(5):625-30. PubMed ID: 7195577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of central and peripheral morphine analgesia by desipramine.
    Ossipov MH; Malseed RT; Goldstein FJ
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):222-9. PubMed ID: 7181579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central effects of 6-hydroxydopamine on the body temperature of the rat.
    Simmonds MA; Uretsky NJ
    Br J Pharmacol; 1970 Dec; 40(4):630-8. PubMed ID: 5495172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-OHDA lesion to the dorsal noradrenergic bundle alters morphine-induced locomotor activity and catalepsy.
    Roberts DC; Mason ST; Fibiger HC
    Eur J Pharmacol; 1978 Nov; 52(2):209-14. PubMed ID: 569587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine.
    Hatip-Al-Khatib I; Mishima K; Iwasaki K; Fujiwara M
    Brain Res; 2001 May; 902(1):108-18. PubMed ID: 11376600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.